Current Value
$8.061 Year Return
Current Value
$8.061 Year Return
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| HTRB | 0.01% | $2.02B | 0.29% |
| STPZ | 0.01% | $450.47M | 0.2% |
| ILTB | 0.02% | $595.04M | 0.06% |
| FLCB | -0.04% | $2.61B | 0.15% |
| AGGH | 0.08% | $324.95M | 0.29% |
| DFCF | 0.15% | $7.09B | 0.17% |
| GSST | -0.16% | $921.46M | 0.16% |
| SPMB | 0.16% | $6.16B | 0.04% |
| AGGY | -0.18% | $793.50M | 0.12% |
| CANE | 0.18% | $10.37M | 0.29% |
| VTIP | 0.24% | $15.33B | 0.03% |
| IBMO | 0.25% | $526.24M | 0.18% |
| AGG | -0.27% | $129.47B | 0.03% |
| JPIB | 0.27% | $910.86M | 0.5% |
| UITB | -0.29% | $2.34B | 0.39% |
| CMBS | 0.29% | $449.66M | 0.25% |
| FBND | 0.30% | $19.27B | 0.36% |
| IBMN | -0.30% | $447.08M | 0.18% |
| IBD | -0.37% | $385.27M | 0.43% |
| BTC | 0.38% | $4.75B | 0.15% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XBI | 33.38% | $4.82B | 0.35% |
| IBB | 32.42% | $5.26B | 0.45% |
| PBE | 29.92% | $223.19M | 0.58% |
| BBH | 29.88% | $330.62M | 0.35% |
| GNOM | 29.35% | $44.57M | 0.5% |
| FBT | 28.77% | $1.01B | 0.54% |
| ARKG | 26.72% | $1.02B | 0.75% |
| PINK | 26.67% | $130.57M | 0.5% |
| VHT | 26.09% | $15.35B | 0.09% |
| XPH | 25.98% | $147.96M | 0.35% |
| FHLC | 25.91% | $2.44B | 0.084% |
| PTH | 25.26% | $100.85M | 0.6% |
| DFEV | 25.09% | $1.04B | 0.43% |
| XSD | 24.73% | $1.29B | 0.35% |
| XLV | 24.55% | $34.28B | 0.09% |
| AAXJ | 24.54% | $2.70B | 0.72% |
| AIA | 24.36% | $750.32M | 0.5% |
| IYH | 24.33% | $2.73B | 0.39% |
| ESGE | 24.06% | $5.01B | 0.26% |
| IXJ | 24.06% | $3.75B | 0.41% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CIG.C | -13.03% | $2.65B | +29.61% | 0.00% |
| VIV | -11.91% | $18.81B | +44.82% | 0.66% |
| CBOE | -11.83% | $24.23B | +35.36% | 1.09% |
| LFVN | -10.90% | $168.68M | +123.71% | 1.22% |
| CME | -10.62% | $99.39B | +40.68% | 3.86% |
| TIMB | -10.34% | $9.76B | +41.79% | 1.97% |
| GO | -10.20% | $1.28B | -39.16% | 0.00% |
| CIG | -10.02% | $3.77B | +11.48% | 0.00% |
| CNTY | -9.45% | $68.42M | -9.35% | 0.00% |
| BAH | -9.38% | $13.43B | -29.93% | 1.93% |
| MFIN | -8.79% | - | - | 4.56% |
| REYN | -8.78% | $4.59B | -20.51% | 4.22% |
| XBIT | -8.65% | $98.17M | -44.39% | 0.00% |
| PULM | -8.10% | $25.57M | +219.63% | 0.00% |
| ED | -8.07% | $36.00B | +12.64% | 3.34% |
| LMT | -7.63% | $108.37B | -0.75% | 2.81% |
| UTZ | -7.52% | $1.14B | -19.23% | 1.82% |
| TEF | -7.28% | $30.08B | +25.41% | 6.16% |
| WDAY | -6.93% | $63.48B | +5.40% | 0.00% |
| MQ | -6.88% | $2.74B | +5.78% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| RUM | 54.33% | $3.27B | +67.83% | 0.00% |
| AVXL | 40.90% | $902.38M | +156.55% | 0.00% |
| HMC | 34.35% | $43.00B | -8.62% | 4.59% |
| TLRY | 32.60% | $503.70M | -71.95% | 0.00% |
| TPST | 30.58% | $29.14M | -74.01% | 0.00% |
| ABBV | 29.79% | $336.94B | +16.42% | 3.35% |
| KALV | 29.72% | $585.65M | +0.51% | 0.00% |
| RXRX | 28.95% | $2.12B | -29.12% | 0.00% |
| PDSB | 28.65% | $58.05M | -57.81% | 0.00% |
| COHU | 27.60% | $953.77M | -38.54% | 0.00% |
| ARCT | 26.82% | $369.38M | -37.89% | 0.00% |
| GCMG | 26.59% | $574.94M | +17.47% | 3.81% |
| AMBA | 25.94% | $2.81B | +16.04% | 0.00% |
| VECO | 25.70% | $1.27B | -55.33% | 0.00% |
| CRNX | 25.65% | $2.76B | -33.39% | 0.00% |
| OCUL | 25.59% | $1.51B | +41.41% | 0.00% |
| MPWR | 25.12% | $36.60B | -8.92% | 0.73% |
| ALEC | 25.12% | $149.99M | -65.99% | 0.00% |
| GFS | 24.74% | $21.87B | -22.05% | 0.00% |
| ATXS | 24.71% | $323.37M | -36.33% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| PG | 0.01% | $377.94B | -1.61% | 2.53% |
| CENT | -0.01% | $2.31B | -5.39% | 0.00% |
| DSP | 0.01% | $832.76M | +28.66% | 0.00% |
| TZOO | -0.01% | $146.68M | +75.10% | 0.00% |
| NGVC | -0.02% | $909.29M | +82.08% | 1.16% |
| EGAN | -0.02% | $185.71M | +7.95% | 0.00% |
| PM | 0.03% | $273.81B | +73.45% | 3.06% |
| NTZ | 0.04% | $39.32M | -25.63% | 0.00% |
| LNG | 0.04% | $53.29B | +38.03% | 0.81% |
| MBI | 0.04% | $216.60M | -19.63% | 0.00% |
| CANG | -0.04% | $354.64M | +215.57% | 0.00% |
| NWN | -0.06% | $1.64B | +14.66% | 4.81% |
| GSHD | 0.08% | $2.57B | +90.79% | 0.00% |
| COR | 0.13% | $56.44B | +30.86% | 0.74% |
| HELE | -0.15% | $763.26M | -63.71% | 0.00% |
| SWX | 0.15% | $5.30B | +3.31% | 3.35% |
| SHEN | 0.15% | $784.46M | -15.03% | 0.69% |
| D | -0.15% | $48.97B | +16.68% | 4.65% |
| SUI | -0.18% | $16.40B | +12.78% | 3.01% |
| CRTO | -0.20% | $1.31B | -37.24% | 0.00% |
Yahoo
SOUTH SAN FRANCISCO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced the appointment of Scott Braunstein, M.D., and Ashley Dombkowski, Ph.D., to its board of directors. Dr. Braunstein was appointed as a member of the Audit Committee of the Board and Dr.
Yahoo
The consensus price target hints at a 282.7% upside potential for Rapt Therapeutics (RAPT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Yahoo
RAPT Therapeutics (RAPT) announced that a 1-for-8 reverse stock split of its outstanding shares of common stock will be effective at 11:59 pm Eastern Time June 16, 2025. Following the reverse stock split, the Company’s common stock will continue to trade on the Nasdaq Global Market under the symbol “RAPT” with the new CUSIP number 75382E 208. The Company’s common stock will begin trading on a reverse stock split-adjusted basis on June 17, 2025. Published first on TheFly – the ultimate source for
Finnhub
Presenter SpeechUnknown Analyst All right. Good morning, everyone. Thanks for joining us here at the Goldman Sachs Annual Healthcare Conference. Thrilled to be joined today by the team from RAPT...
Yahoo
SOUTH SAN FRANCISCO, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that members of the RAPT management team will participate in the following investor conferences in June: Goldman Sachs 46th Annual Global Healthcare Conference – Fireside chat on Tuesd
SeekingAlpha
Although many equity markets slipped in January, they recovered over the next two months for a strong first quarter of 2024.
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -20.08% | $164.54M | 0.85% |
| BTAL | -17.80% | $296.22M | 1.43% |
| TAIL | -16.41% | $99.63M | 0.59% |
| TPMN | -13.07% | $30.70M | 0.65% |
| UNG | -12.41% | $360.54M | 1.06% |
| ULST | -9.65% | $654.75M | 0.2% |
| STOT | -8.67% | $254.07M | 0.45% |
| TFLO | -6.60% | $6.82B | 0.15% |
| AFIF | -6.13% | $140.73M | 1.11% |
| XONE | -5.40% | $625.28M | 0.03% |
| GOVZ | -5.36% | $272.00M | 0.1% |
| LDUR | -5.11% | $929.65M | 0.5% |
| BIL | -4.99% | $42.24B | 0.1356% |
| MEAR | -4.93% | $1.13B | 0.25% |
| GBIL | -4.81% | $6.37B | 0.12% |
| EWZS | -4.66% | $193.07M | 0.6% |
| CTA | -4.47% | $1.06B | 0.76% |
| TYA | -4.35% | $152.69M | 0.15% |
| SPTS | -4.32% | $5.80B | 0.03% |
| FLGV | -4.21% | $1.03B | 0.09% |
